SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy

Abstract

The identification of the SETDB1-mediated suppression of radiotherapy-induced viral mimicry reveals SETDB1 inhibition as a potential approach to sensitize tumors to radiotherapy by enhancing the type I interferon response.